Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy
Jongwutiwes, U.; Malathum, K.; Sungkanuparph, S.
Journal of the Medical Association of Thailand 90 Suppl. 2: 85-88
2007
ISSN/ISBN: 0125-2208 PMID: 19230429 Document Number: 11863
Atypical presentations of cryptococcal infection have been described as clinical manifestations of immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients following commence of antiretroviral therapy (ART). The authors describe a patient presenting with cryptococcal meningoradiculitis two weeks after initiation of ART. In patients with advanced HIV disease, immune reconstitution induced by ART can precipitate onset of atypical clinical manifestations in those patients with latent cryptococcal infection of the central nervous system.
Document emailed within 1 workday
Related Documents
Lugović Mihić, L.; Buljan, M.; Bulat, V.; Situm, M. 2009: Erythema multiforme with reference to atypical presentation in an HIV-positive patient following antiretroviral therapy discontinuation Acta Dermatovenerologica Croatica: Adc 17(1): 9-15Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
MacPherson, P.; Lalloo, D.G.; Webb, E.L.; Maheswaran, H.; Choko, A.T.; Makombe, S.D.; Butterworth, A.E.; van Oosterhout, J.J.; Desmond, N.; Thindwa, D.; Squire, S.B.; Hayes, R.J.; Corbett, E.L. 2014: Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial JAMA 312(4): 372-379
Muhamadi, L.; Tumwesigye, N.M.; Kadobera, D.; Marrone, G.; Wabwire-Mangen, F.; Pariyo, G.; Peterson, S.; Ekström, A.M. 2011: Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda Pan African Medical Journal 8: 40
Kobayashi, T.; Pitisuttithum, P.; Kaewkingwal, J.; Phuphuakrat, A.; Sungkanuparph, S. 2017: Clinical Outcomes of Cryptococcal Meningitis among Hiv-Infected Patients in the Era of Antiretroviral Therapy Southeast Asian Journal of Tropical Medicine and Public Health 48(1): 56-64
Iurin, O.G. 2007: Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy Terapevticheskii Arkhiv 79(11): 67-69
Warley, E.; Fernández Galimberti, G.; Vieni, M.ía.I.és.; Tavella, S.; Salas, M.ón.; Desse, J.; D'Agostino, G.; Szyld, E. 2012: Factors associated to late clinical stage at the initiation of antiretroviral therapy Medicina 72(5): 367-370
Nuwagaba-Biribonwoha, H.; Kiragga, A.N.; Yiannoutsos, C.T.; Musick, B.S.; Wools-Kaloustian, K.K.; Ayaya, S.; Wolf, H.; Lugina, E.; Ssali, J.; Abrams, E.J.; Elul, B. 2018: Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART Journal of the International Aids Society 21(9): E25178
Ndawinz, J.D.A.; Chaix, B.; Koulla-Shiro, S.; Delaporte, E.; Okouda, B.; Abanda, A.; Tchomthe, S.; Mboui, E.; Costagliola, D.; Supervie, V. 2013: Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis Journal of Antimicrobial ChemoTherapy 68(6): 1388-1399
Sempa, J.; Ssennono, M.; Kuznik, A.; Lamorde, M.; Sowinski, S.; Semeere, A.; Hermans, S.; Castelnuovo, B.; Manabe, Y.C. 2012: Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda Bmc Public Health 12: 736
Burgos-Soto, J.; Balestre, E.; Minga, A.; Ajayi, S.; Sawadogo, A.; Zannou, M.D.; Leroy, V.ér.; Ekouevi, D.K.; Dabis, F.ço.; Becquet, R. 2014: Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African countries Journal of Acquired Immune Deficiency Syndromes 67(2): E45-E54
Mavura, D.R.; Masenga, E.J.; Minja, E.; Grossmann, H.; Crump, J.A.; Bartlett, J.A. 2015: Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania International Journal of Dermatology 54(1): 68-73
Tran, D.A.; Shakeshaft, A.; Ngo, A.D.; Mallitt, K.-A.; Wilson, D.; Doran, C.; Zhang, L. 2013: Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam HIV Clinical Trials 14(1): 21-33
Musheke, M.; Bond, V.; Merten, S. 2013: Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study Aids Patient Care and Stds 27(4): 231-241
Dupwa, B.; Kumar, A.M.V.; Tripathy, J.P.; Mugurungi, O.; Takarinda, K.C.; Dzangare, J.; Bara, H.; Mukeredzi, I. 2019: Retesting for verification of HIV diagnosis before antiretroviral therapy initiation in Harare, Zimbabwe: Is there a gap between policy and practice? Transactions of the Royal Society of Tropical Medicine and Hygiene 113(10): 610-616
Adane, A.; Desta, K.; Bezabih, A.; Gashaye, A.; Kassa, D. 2012: HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik Ii Hospital, Addis Ababa, Ethiopia Ethiopian Medical Journal 50(1): 13-21
Siegfried, N.; Uthman, O.A.; Rutherford, G.W. 2010: Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults Cochrane Database of Systematic Reviews 3: Cd008272
Liu, K.C.; Mulindwa, J.; Giganti, M.J.; Putta, N.B.; Chintu, N.; Chi, B.H.; Stringer, J.S.A.; Stringer, E.M. 2011: Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia Journal of Acquired Immune Deficiency Syndromes 57(5): E101-E105
Walker, A.S.; Prendergast, A.J.; Mugyenyi, P.; Munderi, P.; Hakim, J.; Kekitiinwa, A.; Katabira, E.; Gilks, C.F.; Kityo, C.; Nahirya-Ntege, P.; Nathoo, K.; Gibb, D.M.; Grosskurth, H.; Munderi, P.; Kabuye, G.; Nsibambi, D.; Kasirye, R.; Zalwango, E.; Nakazibwe, M.; Kikaire, B.; Nassuna, G.; Massa, R.; Fadhiru, K.; Namyalo, M.; Zalwango, A.; Generous, L.; Khauka, P.; Rutikarayo, N.; Nakahima, W.; Mugisha, A.; Todd, J.; Levin, J.; Muyingo, S.; Ruberantwari, A.; Kaleebu, P.; Yirrell, D.; Ndembi, N.; Lyagoba, F.; Hughes, P.; Aber, M.; Lara, A. M.; Foster, S.; Amurwon, J.; Wakholi, B. N.; Whitworth, J.; Wangati, K.; Amuron, B.; Kajungu, D.; Nakiyingi, J.; Omony, W.; Fadhiru, K.; Nsibambi, D.; Khauka, P.; Mugyenyi, P.; Kityo, C.; Ssali, F.; Tumuku 2012: Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 55(12): 1707-1718
Firnhaber, C.; Smeaton, L.; Saukila, N.; Flanigan, T.; Gangakhedkar, R.; Kumwenda, J.; La Rosa, A.; Kumarasamy, N.; De Gruttola, V.; Hakim, J.Gita.; Campbell, T.B. 2010: Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(12): E1088-E1092